Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)

Egypt flag Egypt · Delayed Price · Currency is EGP
782.27
+0.65 (0.08%)
At close: Feb 22, 2026
Market Cap3.93B +99.2%
Revenue (ttm)2.75B +55.6%
Net Income391.17M +80.5%
EPS78.23 +80.5%
Shares Out5.00M
PE Ratio10.05
Forward PEn/a
Dividend62.95 (8.05%)
Ex-Dividend DateNov 4, 2025
Volume551
Average Volume1,215
Open781.62
Previous Close781.62
Day's Range778.03 - 792.90
52-Week Range395.11 - 1,000.96
Beta-0.07
RSI40.08
Earnings DateFeb 12, 2026

About EGX:AXPH

Alexandria Co. For Pharmaceuticals & Chemical Industries operates as a pharmaceutical company in Egypt. The company manufactures, markets, and distributes branded generics of human and animal health products. It also provides human products, such as tablets, syrups, suppositories, drops, ampoule, and crème; medical appliances; and Veterinary Products. In addition, the company offers antibiotics and anesthetics, ophthalmic, cardiovascular, gastrointestinal, genitourinary, and respiratory drugs. Alexandria Co. For Pharmaceuticals & Chemical Indus... [Read more]

Industry Pharmaceutical Preparations
Founded 1962
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol AXPH
Full Company Profile

Financial Performance

In fiscal year 2025, EGX:AXPH's revenue was 2.75 billion, an increase of 55.56% compared to the previous year's 1.77 billion. Earnings were 391.17 million, an increase of 80.53%.

Financial Statements